骨肉瘤 HER2 靶向治疗的未来:德曲妥珠单抗阴性结果的启示 The Future of HER2-Targeted Treatment for Osteosarcoma: Lessons from the Negative Trastuzumab Deruxtecan Results. PubMed 2023/11/27 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:HER2胃癌乳腺癌骨肉瘤地区:日本